Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | Minor-clone mutations in CLL patients entering first-line treatment

Jitka Malčíková • 21 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Jitka Malčíková, PhD, Masaryk University, Brno, Czech Republic, discusses her poster presentation on minor-clone TP53 mutations in chronic lymphocytic leukemia (CLL) patients entering first-line treatment including the clonal evolution and clinical impact of these mutations. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Jitka Malčíková

1:15
Clinical impact of ATM and TP53 mutations in mantle cell lymphoma
Jitka Malčíková • 21 Sep 2019
2:36
Current knowledge of the TP53 mutation and its role in CLL
Jitka Malčíková • 25 Oct 2018

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals